Gavi evaluation findings and reports

This brief presents findings for Zambia from the 2014 Gavi Full Country Evaluations (FCE) Annual Dissemination Report. It reflects content from the 2014 Annual Dissemination Report. 

This brief presents findings for Uganda from the 2014 Gavi Full Country Evaluations (FCE) Annual Dissemination Report. It reflects content from the 2014 Annual Dissemination Report. 

This brief presents findings for Mozambique from the 2014 Gavi Full Country Evaluations (FCE) Annual Dissemination Report. It reflects content from the 2014 Annual Dissemination Report. 

This brief presents findings for Bangladesh from the 2014 Gavi Full Country Evaluations (FCE) Annual Dissemination Report. It reflects content from the 2014 Annual Dissemination Report.

This brief presents lessons learned from human papillomavirus (HPV) vaccine demonstration in Mozambique and preparation for HPV national introduction in Uganda during the 2014 period of the Gavi Full Country Evaluations (FCE).

This report details findings from the 2014 evaluation period of the Gavi Full Country Evaluations (FCE) project in Bangladesh, Mozambique, Uganda, and Zambia. The FCE are three-year prospective studies that aim to understand and quantify the barriers to and drivers of immunization program performance, with emphasis on the contribution of Gavi, the Vaccine Alliance.

This report details findings from the 2013 evaluation period of the Gavi Full Country Evaluations (FCE) project in Bangladesh, Mozambique, Uganda, and Zambia. The FCE are three-year prospective studies that aim to understand and quantify the barriers to and drivers of immunization program performance, with emphasis on the contribution of Gavi, the Vaccine Alliance.

This report draws from the Gavi Full Country Evaluations project. Produced in January 2014, it details the process evaluation of pneumococcal vaccine introduction in Mozambique, Uganda, and Zambia.